期刊文献+

Curcumin Prevents Induced Drug Resistance:A Novel Function? 被引量:1

Curcumin Prevents Induced Drug Resistance:A Novel Function?
下载PDF
导出
摘要 Objective:We supposed that it will be a promising strategy to "prevent" multidrug resistance (MDR) instead of "reversing" it.This study was designed to investigate the potency of curcumin to prevent the acquired drug resistance induced by adriamycin (ADM) in native K562 cells.Methods:K562 cells were pretreated with curcumin or 0.5% DMSO for 24 h and then were co-incubated with ADM.P-glycoprotein (P-gp) and mdr1 mRNA levels were analyzed separately by flow cytometry and quantitative real-time RT-PCR.The intracellular Rh-123 accumulation was also detected by flow cytometer.Finally,we performed a MTT assay to determine the ADM-induced cytotoxicity with or without pretreatment of curcumin.Results:P-gp and mdr1 mRNA expressions were elevated in the ADM alone group.While in the curcumin pretreated groups,the induced P-gp and mdr1 mRNA levels gradually decreased with increasing curcumin concentrations,and the Rh-123 accumulation level was almost recovered close to the control group's.Finally,the MTT colorimetric assay verified the enhanced effect of curcumin on ADM-induced cytotoxicity.Conclusion:Our present study suggested that curcumin exhibits the novel ability to prevent the up-regulation of P-gp and its mRNA induced by ADM.The prevention capacity is also functionally associated with the elevated intracellular drug accumulation and parallel enhanced ADM cytotoxicity.We revealed a novel function of curcumin as a potential drug resistance preventor. Objective:We supposed that it will be a promising strategy to "prevent" multidrug resistance (MDR) instead of "reversing" it.This study was designed to investigate the potency of curcumin to prevent the acquired drug resistance induced by adriamycin (ADM) in native K562 cells.Methods:K562 cells were pretreated with curcumin or 0.5% DMSO for 24 h and then were co-incubated with ADM.P-glycoprotein (P-gp) and mdr1 mRNA levels were analyzed separately by flow cytometry and quantitative real-time RT-PCR.The intracellular Rh-123 accumulation was also detected by flow cytometer.Finally,we performed a MTT assay to determine the ADM-induced cytotoxicity with or without pretreatment of curcumin.Results:P-gp and mdr1 mRNA expressions were elevated in the ADM alone group.While in the curcumin pretreated groups,the induced P-gp and mdr1 mRNA levels gradually decreased with increasing curcumin concentrations,and the Rh-123 accumulation level was almost recovered close to the control group's.Finally,the MTT colorimetric assay verified the enhanced effect of curcumin on ADM-induced cytotoxicity.Conclusion:Our present study suggested that curcumin exhibits the novel ability to prevent the up-regulation of P-gp and its mRNA induced by ADM.The prevention capacity is also functionally associated with the elevated intracellular drug accumulation and parallel enhanced ADM cytotoxicity.We revealed a novel function of curcumin as a potential drug resistance preventor.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2011年第3期218-223,共6页 中国癌症研究(英文版)
基金 supported by the National Natural Science Foundation ofChina (No. 30901741) Zhejiang Provincial Natural Science Foundation(No. Y2080308)
关键词 CURCUMIN Drug resistance P-GLYCOPROTEIN K562 cell Curcumin Drug resistance P-glycoprotein K562 cell
  • 相关文献

参考文献2

二级参考文献36

  • 1[9]Endo K, Maehara Y, Kusumoto T, et al. Expression of multidrug-resistance-associated protein(MRP) and chemosensitivity in human gastric cancer[J]. In J Cancer 1996; 68: 372-7.
  • 2[10]Zampieri L, Bianchi P, Ruff P, et al. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells[J]. Anticancer Res 2002; 22: 2253-59.
  • 3[11]Del Bufalo D, Biroccio A, Trisciuoglio D, et al. Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used[J]. Eur J Cancer 2002; 38: 2455-62.
  • 4[12]Burger H, Foekens JA, Look MP, et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response[J]. Clin Cancer Res 2003; 9: 827-36.
  • 5[13]Shabbits JA, Mayer LD. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs[J]. Mol Cancer Ther 2002; 1: 205-13.
  • 6[14]Zampieri L, Bianchi P, Ruff P,et al. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells[J]. Anticancer Res 2002; 22: 2253-9.
  • 7[15]Sauer G, Kafka A, Grundmann R, et al. Basal expression of the multidrug resistance gene 1 (MDR-1) is associated with the TT genotype at the polymorphic site C3435T in mammary and ovarian carcinoma cell lines[J]. Cancer Lett 2002; 185: 79-85.
  • 8[16]Filipits M, Malayeri R, Suchomel RW, et al. Expression of the multidrug resistance protein (MRP1) in breast cancer[J]. Anticancer Res 1999; 19: 5043-9.
  • 9[17]Yang X, Uziely B, Groshen S,et al. MDR1 gene expression in primary and advanced breast cancer[J]. Lab Invest 1999; 79: 271-80.
  • 10[18]Nakamura T, Oka M, Aizawa K, et al. Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein(MRP) in human gastric cancer cells[J]. Biochem Biophys Res Commun 1999; 255: 618-24.

共引文献5

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部